Erschienen in:
01.03.2010 | Letter to the Editor
Development of Kaposi’s sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient
verfasst von:
Alastair B. Law, Gail Ryan, Stephen Lade, H. Miles Prince
Erschienen in:
International Journal of Hematology
|
Ausgabe 2/2010
Einloggen, um Zugang zu erhalten
Excerpt
We read with interest the report in this journal about HHV8-positive, HIV-negative multicentric Castleman’s disease (MCD) with early and sustained complete remission with rituximab therapy without reactivation of Kaposi’s sarcoma (KS) [
1]. Unlike their report, we report a patient with HIV-negative MCD who was successfully treated with rituximab-based therapy, but who shortly after completion of treatment developed aggressive KS. …